PMHS · Polomar Health Services, Inc.
$0.30
At close · Aug 26
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the financial statements are issued and determined that substantial doubt exists about the Company's ability to continue as a going concern. The Company's ability to continue as a going concern is dependent on the Company's ability to generate revenues and raise capital. The Company has not generated sufficient income and has historically depended on notes or equity to fund operations. As of June 30, 2026, the Company has an accumulated deficit of $13,526,169. These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the date of filing of the 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.51M
Shares
28.38M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.30
Open$0.25
Day$0.25–0.30
52W close$0.07–0.80
Avg vol 30d7K
Short int5K · 0.0% float · 1.0d
Short vol81%
DataNov 2024–Aug 2026
Filing10-Q · Aug 14
Raw chart and full-history price indicators begin at the captured split on Nov 1, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+45%
above
RSI (14)
56
neutral
MACD trend
Positive
52-week position
32%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+100%
trailing
YTD return
−63%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +1372.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
48
elevated · 0–100
Fundamentals
Revenue growth
+1002%
Y/Y
Gross margin
71%
expanding
EPS growth
−680%
Y/Y
Free cash flow
$-486.9K
Quant / Vol
risk profile
Volatility
1810%
annualized · 1-yr
Max drawdown
−92%
past year
ATR
26.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+45%
Bullish
RSI (14)
56
Neutral
MACD trend
Positive
Bullish
52-week position
32%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +1372.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 32%
Range high $1
vs 50-day avg +45%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Pharmaceutical Retailers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PMHS
this stock
Polomar Health Services, Inc.
|
$8.51M | -62.5% | +1002.0% | — | 0.0% |
|
RTEZ
REST EZ Inc.
|
$4.20B | — | -100.0% | — | 0.0% |
|
HITI
High Tide Inc.
|
$220.55M | -5.3% | — | — | 0.7% |
|
SHFH
Scientist Home Future Health Ltd
|
$189.73M | — | — | — | — |
|
BHIC
BioScience Health Innovations, Inc.
|
$58.53M | — | +208.3% | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Nov 1, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PMHS | +114.3% | +100.0% | — | +275.0% | -62.5% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +114.7% | +95.0% | — | +272.5% | -74.8% |